Researchers have developed a novel method to control a notorious protein, MYC, which plays a pivotal role in the progression of three in four human cancer cases.
A recent phase II clinical trial has revealed that psilocybin, the hallucinogenic compound found in certain mushrooms, may offer significant benefits for individuals with cancer and major depression.
Researchers from Brigham and Women’s Hospital have developed a tiny device to help doctors better understand and treat gliomas -- stubborn brain and spinal cord tumors.